Charles Mikel, Ph.D.

Ph.D., Research Scientist
Vice President, Chief Scientific Officer, Millennium Laboratories

As Vice President/Chief Scientific Officer, Dr. Charles Mikel provides scientific leadership and direction to the laboratory operations and R & D programs at Millennium Laboratories. Dr. Mikel is credited with originating the innovative drug testing methods, specimen handling and data processing systems used in Millennium Laboratories state-of-the-art facilities.

Prior to joining Millennium Laboratories at its inception, Dr. Mikel was a founding scientist at Chembridge Research Laboratories (CRL) in San Diego, CA. As a group leader in the contract research medicinal chemistry group, Dr. Mikel’s research advanced early-stage drug discovery for several leading pharmaceutical companies, including Pfizer, Astra-Zeneca, Merck, Boehringer-Ingelheim and Takeda.

Dr. Mikel has published 30+ research papers and holds several U.S. and international patents related to toxicology, medicinal chemistry and combinatorial chemistry. Dr. Mikel has also published several papers on organo-metallic macromolecular catalysts for use in hydrogen-based fuel cells. Dr. Mikel holds a PhD in Synthetic Organic Chemistry from York University in Toronto, Canada.